Join to View Full Profile
747 52nd StOakland, CA 94609
Phone+1 510-428-3058
Fax+1 510-450-5813
Dr. Harmatz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Gastroenterology, 1979 - 1982
Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 1976 - 1979
Geisel School of Medicine at DartmouthClass of 1976
Certifications & Licensure
AZ State Medical License 2023 - 2027
CA State Medical License 1977 - 2027
CO State Medical License 2023 - 2027
FL State Medical License 2021 - 2027
GA State Medical License 2022 - 2027
MI State Medical License 2024 - 2027
NH State Medical License 2021 - 2027
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Gastroenterology
- Join now to see all
Clinical Trials
- Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment Start of enrollment: 2006 Feb 01
- Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
- A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial.Eugen Mengel, Rosalia M Da Riol, Mireia Del Toro, Federica Deodato, Matthias Gautschi
Molecular Genetics and Metabolism. 2025-08-01 - Long-term enzyme replacement therapy: Findings from the mucopolysaccharidosis VI clinical surveillance program after 15 years follow-up.Barbara K Burton, Paul R Harmatz, Veronika Horvathova, Alice Lail, Christina Lampe
Molecular Genetics and Metabolism. 2025-07-01 - Unmet needs of adults living with mucopolysaccharidosis II: data from the Hunter Outcome Survey.Joseph Muenzer, Hernan Amartino, Roberto Giugliani, Paul Harmatz, Shuan-Pei Lin
Orphanet Journal of Rare Diseases. 2025-07-01
Press Mentions
Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B (MPS IIIB)August 14th, 2025
REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025January 30th, 2025- Rare, Deadly Genetic Disease Successfully Treated in Utero for First TimeNovember 9th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
